ALPMY Stock Astellas Pharma (ALPMY, $9.82) was a top winner yesterday, jumping +3.26%

GET DAILY SIGNALS

Get AI intraday signals

ALPMY - Astellas Pharma, Inc.

Loading...

Price: $9.82

Daily change: +$0.31 (+3.26%)

Daily volume: 1.1M

Capitalization: $17.5B

Industry: Pharmaceuticals: Major

Astellas Pharma (ALPMY, $9.82) was one of the top gainers yesterday, rising to $9.82 per share. A.I.dvisor analyzed 58 stocks in the Pharmaceuticals: Major Industry and found that of them (7) are in an Uptrend while of them (2) are in a Downtrend.

Aroon Indicator for ALPMY shows an upward move is likely

ALPMY's Aroon Indicator triggered a bullish signal on November 12, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 210 similar instances where the Aroon Indicator showed a similar pattern. In of the 210 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 03, 2025. You may want to consider a long position or call options on ALPMY as a result. In of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ALPMY just turned positive on October 30, 2025. Looking at past instances where ALPMY's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

ALPMY moved above its 50-day moving average on November 04, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ALPMY crossed bullishly above the 50-day moving average on November 11, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALPMY advanced for three days, in of 297 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

ALPMY broke above its upper Bollinger Band on November 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.058) is normal, around the industry mean (9.612). P/E Ratio (26.539) is within average values for comparable stocks, (23.835). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.037). ALPMY has a moderately high Dividend Yield (0.042) as compared to the industry average of (0.028). P/S Ratio (1.659) is also within normal values, averaging (3.560).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALPMY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALPMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.